Electrochemical sensors
Electrochemical sensors using Canatu CNT provide portable, affordable and easy to use method for point-of-use clinical analyses, and feature high sensitivity with unparalleled signal-to-noise ratio.
Unique structural and catalytic properties
The inherently large specific surface area, high conductivity, and tailorable surface chemistry makes Canatu CNT films an ideal electrode material for biosensor development. Canatu’s unique dry deposition method enables mass production of highly repeatable CNT films with large electrochemically active surface area and high signal-to-noise ratio.
These high purity CNT films can be controllably functionalized to allow for a wide range of chemical modifications and immobilization chemistries while preserving the high sensitivity.
Electrochemical sensors using Canatu CNT’s offer:
- high electrical conductivity and surface area
- high sensitivity and signal-to-noise ratio
- highly repeatable electrode platform
- proven scalability of production process
Biosensors for medical diagnostics
Canatu CNT biosensors have the potential to transform medical diagnostics, improving drug concentration measurements, dosing, and overdose diagnosis. It’s a highly repeatable electrochemical transducer platform that enhances biosensor development and can be customized for specific immobilization protocols.
Contact our specialist in electrochemical sensors
Send us a message
Related content
Opioid misuse and access to care continue to be key challenges. Simpler and inexpensive lab-level tests with rapid results will give caregivers better means to determine personalized patient care at the point-of-use. See our role in advancing medical diagnostics.
Canatu has a versatile platform for biosensor development. Electrochemical sensors using Canatu CNTs have the potential to provide resilient, accurate, reliable, and low-cost analysis in clinical, industrial, environmental, food safety and agricultural sectors. See the platform.
Canatu CNT -based electrochemical sensors for bedside blood concentration measurement progresses to clinical studies. The new point-of-use measurement enables real-time detection of analgesics from blood without extensive sample treatment, improving test result wait time, cost and convenience. See press release.
Finnish ecosystem spurs diagnostics development. Canatu will develop a new hybrid electrochemical sensor for target detection and drug concentration measurement. See press release.
Canatu creates nano solutions for massive impact. We work with carbon, the most versatile material in the universe, and collaborate with other forerunner companies to make breakthrough innovations. See our company.
Canatu partners with forerunner companies, research partners and a leading Finnish University Hospital, together transforming products for better tomorrows with nano carbon. See how we collaborate for an impact.
Canatu CNTs feature clean surface ensuring large contact with the analyte, and high electrical conductivity, contributing to strong signal and low detection limit. Discover unique properties.
